Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2010 Dec; 51(12):2222-9.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Bevacizumab
Female
Humans
Indoles
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Pyrroles
Quinazolines
Treatment Outcome
Vascular Endothelial Growth Factor A
authors with profiles
Asish K Ghosh